0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharma-Grade Hyaluronic Acid Market Research Report 2026
Published Date: 2026-04-02
|
Report Code: QYRE-Auto-1V9366
Home | Market Reports
Global Pharma Grade Hyaluronic Acid Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pharma-Grade Hyaluronic Acid Market Research Report 2026

Code: QYRE-Auto-1V9366
Report
2026-04-02
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharma-Grade Hyaluronic Acid Market Size

The global Pharma-Grade Hyaluronic Acid market was valued at US$ 221 million in 2025 and is anticipated to reach US$ 436 million by 2032, at a CAGR of 10.3% from 2026 to 2032.

Pharma-Grade Hyaluronic Acid Market

Pharma-Grade Hyaluronic Acid Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharma-Grade Hyaluronic Acid competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hyaluronic acid is a naturally occurring substance that helps retain moisture in the skin and eyes and lubricates the joints. Pharma-Grade Hyaluronic Acid is generally used in pharmaceutical formulations, such as Injection Product and Eye Drops for osteoarthritis of the knee joint.
Hyaluronic acid also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique among glycosaminoglycans in that it is nonsulfated, forms in the plasma membrane instead of the Golgi apparatus, and can be very large: human synovial HA averages about 7 million Da per molecule, or about 20000 disaccharide monomers, while other sources mention 3–4 million Da. As one of the chief components of the extracellular matrix, hyaluronan contributes significantly to cell proliferation and migration, and may also be involved in the progression of some malignant tumors. In this report, we only study the Pharma-Grade Hyaluronic Acid.
The rising preference rates and applications of hyaluronic acid products in dry eye and osteoarthritis management fuels the growth rate of the market significantly. the growing prevalence of osteoarthritis has fueled demand for hyaluronic acid-based treatments, as it is used in viscosupplementation injections to relieve joint pain. Rising consumer awareness of health, along with advancements in biotechnology, has further expanded the market's growth.
However, adverse effects associated with treatment or therapy such as redness and itching, as well as high production costs and regulatory hurdles. The process of extracting and purifying hyaluronic acid, particularly from natural sources, can be expensive, leading to higher product prices. Additionally, the stringent regulatory requirements for pharmaceutical-grade products create barriers for manufacturers, as they must meet rigorous standards for safety and efficacy. These factors can limit the entry of new players into the market and slow down overall growth.
Global key players of pharma-grade hyaluronic acid include Bloomage Biotech, HTL Biotechnology, Kewpie, Contipro, Fidia Farmaceutici, etc. The top five players hold a share about 78%. Europe is the largest market, has a share about 51%, followed by North America and Asia-Pacific , with share 26% and 21%, separately.
This report delivers a comprehensive overview of the global Pharma-Grade Hyaluronic Acid market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharma-Grade Hyaluronic Acid. The Pharma-Grade Hyaluronic Acid market size, estimates, and forecasts are provided in terms of sales volume (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharma-Grade Hyaluronic Acid market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharma-Grade Hyaluronic Acid manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Pharma-Grade Hyaluronic Acid Market Report

Report Metric Details
Report Name Pharma-Grade Hyaluronic Acid Market
Accounted market size in 2025 US$ 221 million
Forecasted market size in 2032 US$ 436 million
CAGR 10.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Microbial Fermentation
  • Animal Tissue
by Application
  • Injection Product
  • Eye Drops
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bloomage Biotech, AWA Biopharm, Kewpie, Contipro, Seikagaku, HTL Biotechnology, Fidia Farmaceutici
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Pharma-Grade Hyaluronic Acid manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Pharma-Grade Hyaluronic Acid sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Pharma-Grade Hyaluronic Acid Market growing?

Ans: The Pharma-Grade Hyaluronic Acid Market witnessing a CAGR of 10.3% during the forecast period 2026-2032.

What is the Pharma-Grade Hyaluronic Acid Market size in 2032?

Ans: The Pharma-Grade Hyaluronic Acid Market size in 2032 will be US$ 436 million.

What is the market share of major companies in Pharma-Grade Hyaluronic Acid Market?

Ans: The top five players hold a share about 78%.

What is the Pharma-Grade Hyaluronic Acid Market share by region?

Ans: Europe is the largest market, has a share about 51%, followed by North America and Asia-Pacific , with share 26% and 21%, separately.

Who are the main players in the Pharma-Grade Hyaluronic Acid Market report?

Ans: The main players in the Pharma-Grade Hyaluronic Acid Market are Bloomage Biotech, AWA Biopharm, Kewpie, Contipro, Seikagaku, HTL Biotechnology, Fidia Farmaceutici

What are the Application segmentation covered in the Pharma-Grade Hyaluronic Acid Market report?

Ans: The Applications covered in the Pharma-Grade Hyaluronic Acid Market report are Injection Product, Eye Drops

What are the Type segmentation covered in the Pharma-Grade Hyaluronic Acid Market report?

Ans: The Types covered in the Pharma-Grade Hyaluronic Acid Market report are Microbial Fermentation, Animal Tissue

1 Pharma-Grade Hyaluronic Acid Market Overview
1.1 Product Definition
1.2 Pharma-Grade Hyaluronic Acid by Type
1.2.1 Global Pharma-Grade Hyaluronic Acid Market Value by Type: 2025 vs 2032
1.2.2 Microbial Fermentation
1.2.3 Animal Tissue
1.3 Pharma-Grade Hyaluronic Acid by Application
1.3.1 Global Pharma-Grade Hyaluronic Acid Market Value by Application: 2025 vs 2032
1.3.2 Injection Product
1.3.3 Eye Drops
1.4 Global Pharma-Grade Hyaluronic Acid Market Size Estimates and Forecasts
1.4.1 Global Pharma-Grade Hyaluronic Acid Revenue 2021–2032
1.4.2 Global Pharma-Grade Hyaluronic Acid Sales 2021–2032
1.4.3 Global Pharma-Grade Hyaluronic Acid Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pharma-Grade Hyaluronic Acid Market Competition by Manufacturers
2.1 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pharma-Grade Hyaluronic Acid Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pharma-Grade Hyaluronic Acid, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pharma-Grade Hyaluronic Acid, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pharma-Grade Hyaluronic Acid, Product Types and Applications
2.7 Global Key Manufacturers of Pharma-Grade Hyaluronic Acid, Date of Entry into the Industry
2.8 Global Pharma-Grade Hyaluronic Acid Market Competitive Situation and Trends
2.8.1 Global Pharma-Grade Hyaluronic Acid Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pharma-Grade Hyaluronic Acid Players Market Share by Revenue
2.8.3 Global Pharma-Grade Hyaluronic Acid Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharma-Grade Hyaluronic Acid Market Scenario by Region
3.1 Global Pharma-Grade Hyaluronic Acid Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pharma-Grade Hyaluronic Acid Sales by Region: 2021–2032
3.2.1 Global Pharma-Grade Hyaluronic Acid Sales by Region: 2021–2026
3.2.2 Global Pharma-Grade Hyaluronic Acid Sales by Region: 2027–2032
3.3 Global Pharma-Grade Hyaluronic Acid Revenue by Region: 2021–2032
3.3.1 Global Pharma-Grade Hyaluronic Acid Revenue by Region: 2021–2026
3.3.2 Global Pharma-Grade Hyaluronic Acid Revenue by Region: 2027–2032
3.4 North America Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
3.4.1 North America Pharma-Grade Hyaluronic Acid Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pharma-Grade Hyaluronic Acid Sales by Country (2021–2032)
3.4.3 North America Pharma-Grade Hyaluronic Acid Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
3.5.1 Europe Pharma-Grade Hyaluronic Acid Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pharma-Grade Hyaluronic Acid Sales by Country (2021–2032)
3.5.3 Europe Pharma-Grade Hyaluronic Acid Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharma-Grade Hyaluronic Acid Market Facts & Figures by Region
3.6.1 Asia Pacific Pharma-Grade Hyaluronic Acid Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Region (2021–2032)
3.6.3 Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
3.7.1 Latin America Pharma-Grade Hyaluronic Acid Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pharma-Grade Hyaluronic Acid Sales by Country (2021–2032)
3.7.3 Latin America Pharma-Grade Hyaluronic Acid Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharma-Grade Hyaluronic Acid Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharma-Grade Hyaluronic Acid Sales by Type (2021–2032)
4.1.1 Global Pharma-Grade Hyaluronic Acid Sales by Type (2021–2026)
4.1.2 Global Pharma-Grade Hyaluronic Acid Sales by Type (2027–2032)
4.1.3 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Type (2021–2032)
4.2 Global Pharma-Grade Hyaluronic Acid Revenue by Type (2021–2032)
4.2.1 Global Pharma-Grade Hyaluronic Acid Revenue by Type (2021–2026)
4.2.2 Global Pharma-Grade Hyaluronic Acid Revenue by Type (2027–2032)
4.2.3 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Type (2021–2032)
4.3 Global Pharma-Grade Hyaluronic Acid Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pharma-Grade Hyaluronic Acid Sales by Application (2021–2032)
5.1.1 Global Pharma-Grade Hyaluronic Acid Sales by Application (2021–2026)
5.1.2 Global Pharma-Grade Hyaluronic Acid Sales by Application (2027–2032)
5.1.3 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Application (2021–2032)
5.2 Global Pharma-Grade Hyaluronic Acid Revenue by Application (2021–2032)
5.2.1 Global Pharma-Grade Hyaluronic Acid Revenue by Application (2021–2026)
5.2.2 Global Pharma-Grade Hyaluronic Acid Revenue by Application (2027–2032)
5.2.3 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Application (2021–2032)
5.3 Global Pharma-Grade Hyaluronic Acid Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bloomage Biotech
6.1.1 Bloomage Biotech Company Information
6.1.2 Bloomage Biotech Description and Business Overview
6.1.3 Bloomage Biotech Pharma-Grade Hyaluronic Acid Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bloomage Biotech Pharma-Grade Hyaluronic Acid Product Portfolio
6.1.5 Bloomage Biotech Recent Developments/Updates
6.2 AWA Biopharm
6.2.1 AWA Biopharm Company Information
6.2.2 AWA Biopharm Description and Business Overview
6.2.3 AWA Biopharm Pharma-Grade Hyaluronic Acid Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AWA Biopharm Pharma-Grade Hyaluronic Acid Product Portfolio
6.2.5 AWA Biopharm Recent Developments/Updates
6.3 Kewpie
6.3.1 Kewpie Company Information
6.3.2 Kewpie Description and Business Overview
6.3.3 Kewpie Pharma-Grade Hyaluronic Acid Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Kewpie Pharma-Grade Hyaluronic Acid Product Portfolio
6.3.5 Kewpie Recent Developments/Updates
6.4 Contipro
6.4.1 Contipro Company Information
6.4.2 Contipro Description and Business Overview
6.4.3 Contipro Pharma-Grade Hyaluronic Acid Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Contipro Pharma-Grade Hyaluronic Acid Product Portfolio
6.4.5 Contipro Recent Developments/Updates
6.5 Seikagaku
6.5.1 Seikagaku Company Information
6.5.2 Seikagaku Description and Business Overview
6.5.3 Seikagaku Pharma-Grade Hyaluronic Acid Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Seikagaku Pharma-Grade Hyaluronic Acid Product Portfolio
6.5.5 Seikagaku Recent Developments/Updates
6.6 HTL Biotechnology
6.6.1 HTL Biotechnology Company Information
6.6.2 HTL Biotechnology Description and Business Overview
6.6.3 HTL Biotechnology Pharma-Grade Hyaluronic Acid Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 HTL Biotechnology Pharma-Grade Hyaluronic Acid Product Portfolio
6.6.5 HTL Biotechnology Recent Developments/Updates
6.7 Fidia Farmaceutici
6.7.1 Fidia Farmaceutici Company Information
6.7.2 Fidia Farmaceutici Description and Business Overview
6.7.3 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Product Portfolio
6.7.5 Fidia Farmaceutici Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharma-Grade Hyaluronic Acid Industry Chain Analysis
7.2 Pharma-Grade Hyaluronic Acid Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharma-Grade Hyaluronic Acid Production Mode & Process Analysis
7.4 Pharma-Grade Hyaluronic Acid Sales and Marketing
7.4.1 Pharma-Grade Hyaluronic Acid Sales Channels
7.4.2 Pharma-Grade Hyaluronic Acid Distributors
7.5 Pharma-Grade Hyaluronic Acid Customer Analysis
8 Pharma-Grade Hyaluronic Acid Market Dynamics
8.1 Pharma-Grade Hyaluronic Acid Industry Trends
8.2 Pharma-Grade Hyaluronic Acid Market Drivers
8.3 Pharma-Grade Hyaluronic Acid Market Challenges
8.4 Pharma-Grade Hyaluronic Acid Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pharma-Grade Hyaluronic Acid Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Pharma-Grade Hyaluronic Acid Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Pharma-Grade Hyaluronic Acid Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Pharma-Grade Hyaluronic Acid Sales (Kg) of Key Manufacturers (2021–2026)
 Table 5. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Pharma-Grade Hyaluronic Acid Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Pharma-Grade Hyaluronic Acid Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Pharma-Grade Hyaluronic Acid Average Price (US$/Kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Pharma-Grade Hyaluronic Acid, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Pharma-Grade Hyaluronic Acid, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Pharma-Grade Hyaluronic Acid, Product Types and Applications
 Table 12. Global Key Manufacturers of Pharma-Grade Hyaluronic Acid, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pharma-Grade Hyaluronic Acid Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharma-Grade Hyaluronic Acid Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pharma-Grade Hyaluronic Acid Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Pharma-Grade Hyaluronic Acid Sales by Region (Kg), 2021–2026
 Table 18. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Region (2021–2026)
 Table 19. Global Pharma-Grade Hyaluronic Acid Sales by Region (Kg), 2027–2032
 Table 20. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Region (2027–2032)
 Table 21. Global Pharma-Grade Hyaluronic Acid Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Region (2021–2026)
 Table 23. Global Pharma-Grade Hyaluronic Acid Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Region (2027–2032)
 Table 25. North America Pharma-Grade Hyaluronic Acid Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Pharma-Grade Hyaluronic Acid Sales by Country (Kg), 2021–2026
 Table 27. North America Pharma-Grade Hyaluronic Acid Sales by Country (Kg), 2027–2032
 Table 28. North America Pharma-Grade Hyaluronic Acid Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Pharma-Grade Hyaluronic Acid Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Pharma-Grade Hyaluronic Acid Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Pharma-Grade Hyaluronic Acid Sales by Country (Kg), 2021–2026
 Table 32. Europe Pharma-Grade Hyaluronic Acid Sales by Country (Kg), 2027–2032
 Table 33. Europe Pharma-Grade Hyaluronic Acid Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Pharma-Grade Hyaluronic Acid Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Region (Kg), 2021–2026
 Table 37. Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Region (Kg), 2027–2032
 Table 38. Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Pharma-Grade Hyaluronic Acid Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Pharma-Grade Hyaluronic Acid Sales by Country (Kg), 2021–2026
 Table 42. Latin America Pharma-Grade Hyaluronic Acid Sales by Country (Kg), 2027–2032
 Table 43. Latin America Pharma-Grade Hyaluronic Acid Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Pharma-Grade Hyaluronic Acid Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Country (Kg), 2021–2026
 Table 47. Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Country (Kg), 2027–2032
 Table 48. Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Pharma-Grade Hyaluronic Acid Sales (Kg) by Type (2021–2026)
 Table 51. Global Pharma-Grade Hyaluronic Acid Sales (Kg) by Type (2027–2032)
 Table 52. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Type (2021–2026)
 Table 53. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Type (2027–2032)
 Table 54. Global Pharma-Grade Hyaluronic Acid Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Pharma-Grade Hyaluronic Acid Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Type (2021–2026)
 Table 57. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Type (2027–2032)
 Table 58. Global Pharma-Grade Hyaluronic Acid Price (US$/Kg) by Type (2021–2026)
 Table 59. Global Pharma-Grade Hyaluronic Acid Price (US$/Kg) by Type (2027–2032)
 Table 60. Global Pharma-Grade Hyaluronic Acid Sales (Kg) by Application (2021–2026)
 Table 61. Global Pharma-Grade Hyaluronic Acid Sales (Kg) by Application (2027–2032)
 Table 62. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Application (2021–2026)
 Table 63. Global Pharma-Grade Hyaluronic Acid Sales Market Share by Application (2027–2032)
 Table 64. Global Pharma-Grade Hyaluronic Acid Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Pharma-Grade Hyaluronic Acid Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Application (2021–2026)
 Table 67. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Application (2027–2032)
 Table 68. Global Pharma-Grade Hyaluronic Acid Price (US$/Kg) by Application (2021–2026)
 Table 69. Global Pharma-Grade Hyaluronic Acid Price (US$/Kg) by Application (2027–2032)
 Table 70. Bloomage Biotech Company Information
 Table 71. Bloomage Biotech Description and Business Overview
 Table 72. Bloomage Biotech Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 73. Bloomage Biotech Pharma-Grade Hyaluronic Acid Product
 Table 74. Bloomage Biotech Recent Developments/Updates
 Table 75. AWA Biopharm Company Information
 Table 76. AWA Biopharm Description and Business Overview
 Table 77. AWA Biopharm Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 78. AWA Biopharm Pharma-Grade Hyaluronic Acid Product
 Table 79. AWA Biopharm Recent Developments/Updates
 Table 80. Kewpie Company Information
 Table 81. Kewpie Description and Business Overview
 Table 82. Kewpie Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 83. Kewpie Pharma-Grade Hyaluronic Acid Product
 Table 84. Kewpie Recent Developments/Updates
 Table 85. Contipro Company Information
 Table 86. Contipro Description and Business Overview
 Table 87. Contipro Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 88. Contipro Pharma-Grade Hyaluronic Acid Product
 Table 89. Contipro Recent Developments/Updates
 Table 90. Seikagaku Company Information
 Table 91. Seikagaku Description and Business Overview
 Table 92. Seikagaku Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 93. Seikagaku Pharma-Grade Hyaluronic Acid Product
 Table 94. Seikagaku Recent Developments/Updates
 Table 95. HTL Biotechnology Company Information
 Table 96. HTL Biotechnology Description and Business Overview
 Table 97. HTL Biotechnology Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 98. HTL Biotechnology Pharma-Grade Hyaluronic Acid Product
 Table 99. HTL Biotechnology Recent Developments/Updates
 Table 100. Fidia Farmaceutici Company Information
 Table 101. Fidia Farmaceutici Description and Business Overview
 Table 102. Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 103. Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Product
 Table 104. Fidia Farmaceutici Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Pharma-Grade Hyaluronic Acid Distributors List
 Table 108. Pharma-Grade Hyaluronic Acid Customers List
 Table 109. Pharma-Grade Hyaluronic Acid Market Trends
 Table 110. Pharma-Grade Hyaluronic Acid Market Drivers
 Table 111. Pharma-Grade Hyaluronic Acid Market Challenges
 Table 112. Pharma-Grade Hyaluronic Acid Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pharma-Grade Hyaluronic Acid
 Figure 2. Global Pharma-Grade Hyaluronic Acid Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Pharma-Grade Hyaluronic Acid Market Share by Type: 2025 & 2032
 Figure 4. Microbial Fermentation Product Picture
 Figure 5. Animal Tissue Product Picture
 Figure 6. Global Pharma-Grade Hyaluronic Acid Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Pharma-Grade Hyaluronic Acid Market Share by Application: 2025 & 2032
 Figure 8. Injection Product
 Figure 9. Eye Drops
 Figure 10. Global Pharma-Grade Hyaluronic Acid Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Pharma-Grade Hyaluronic Acid Market Size (US$ Million), 2021–2032
 Figure 12. Global Pharma-Grade Hyaluronic Acid Sales (Kg), 2021–2032
 Figure 13. Global Pharma-Grade Hyaluronic Acid Average Price (US$/Kg), 2021–2032
 Figure 14. Pharma-Grade Hyaluronic Acid Report Years Considered
 Figure 15. Pharma-Grade Hyaluronic Acid Sales Share by Manufacturers in 2025
 Figure 16. Global Pharma-Grade Hyaluronic Acid Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Pharma-Grade Hyaluronic Acid Players: Market Share by Revenue in Pharma-Grade Hyaluronic Acid in 2025
 Figure 18. Pharma-Grade Hyaluronic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Pharma-Grade Hyaluronic Acid Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Pharma-Grade Hyaluronic Acid Sales Market Share by Country (2021–2032)
 Figure 21. North America Pharma-Grade Hyaluronic Acid Revenue Market Share by Country (2021–2032)
 Figure 22. United States Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Pharma-Grade Hyaluronic Acid Sales Market Share by Country (2021–2032)
 Figure 25. Europe Pharma-Grade Hyaluronic Acid Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Pharma-Grade Hyaluronic Acid Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Pharma-Grade Hyaluronic Acid Revenue Market Share by Region (2021–2032)
 Figure 33. China Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Indonesia Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Thailand Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Malaysia Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Pharma-Grade Hyaluronic Acid Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Pharma-Grade Hyaluronic Acid Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Pharma-Grade Hyaluronic Acid Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Pharma-Grade Hyaluronic Acid Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Pharma-Grade Hyaluronic Acid by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Pharma-Grade Hyaluronic Acid by Type (2021–2032)
 Figure 54. Global Pharma-Grade Hyaluronic Acid Price (US$/Kg) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Pharma-Grade Hyaluronic Acid by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Pharma-Grade Hyaluronic Acid by Application (2021–2032)
 Figure 57. Global Pharma-Grade Hyaluronic Acid Price (US$/Kg) by Application (2021–2032)
 Figure 58. Pharma-Grade Hyaluronic Acid Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS